Emerging Economies’ New Initiative On Falsified And Substandard Medicines 22/10/2010 by William New and Kaitlin Mara for Intellectual Property Watch 2 Comments Several major generic-medicine producing nations last week held a discussion on the dangers of compromised medical products and joined together to urge new steps such as defining terms, focussing on public health and strengthening national regulatory capabilities beyond strictly enforcement actions that they say have been manipulated and at times counterproductive.
Indigenous Groups Allege Canadian Obstructionism To Biodiversity ABS Protocol 21/10/2010 by Catherine Saez, Intellectual Property Watch Leave a Comment NAGOYA, JAPAN – With the clock ticking and less than a day to go before a draft of a legally binding instrument to prevent biopiracy is due to be presented to the assembly of a major United Nations meeting on biodiversity, delegations kept trying to find acceptable language, with different echoes coming from the negotiating room. Meanwhile, Canadian indigenous people convened a press briefing today (21 October) to charge that Canada was trying to block the negotiations and deny their human rights.
Stakeholders Restless About Biodiversity Benefit Sharing Protocol 21/10/2010 by Catherine Saez, Intellectual Property Watch Leave a Comment NAGOYA, JAPAN – Negotiations on a legal international instrument to prevent biopiracy and ensure that resource holders are compensated on Thursday continued to demand the attention of delegates in the closed-door discussions here. Meanwhile, civil society argued that the Convention on Biological Diversity is at a critical point while a research institute provided a model agreement for providers and users of genetic resources.
Draft Report Of Plant Variety Protection Council Now Available 21/10/2010 by Intellectual Property Watch Leave a Comment The International Union for the Protection of New Varieties of Plants (UPOV) held its Council meeting on 21 October, approving the participation of two public interest groups that were rejected at a previous meeting as observers to the Council (IPW, WIPO, 28 March 2010). The draft summary for the press of the Council meeting is […]
NGOs: Biopiracy Ongoing As Governments Slowly Negotiate International Instrument 21/10/2010 by Catherine Saez, Intellectual Property Watch Leave a Comment NAGOYA, JAPAN – Discussions on a draft protocol to prevent biopiracy were intense again on Wednesday, with night sessions going late as delegation try to find common language on a legally binding instrument. Around the discussions, undertaken mostly behind closed doors, side events convened by civil society are warning about numerous cases of biopiracy, and the urgent need for a meaningful protocol.
Minister: India Anticipates European Fix To Law Delaying Generics Shipments 20/10/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment Europe has promised at the “highest levels” to fix laws that caused generic medicine seizures in the Netherlands, the Indian Minister of Commerce and Industry said today. The minister is in Geneva for meetings on the ongoing Doha Round trade liberalisation talks at the World Trade Organization.
Copyright Industry Makes Pitch For Economic Benefit Of Anti-Piracy In Developing Countries 20/10/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment Copyright law is not always a barrier to access to knowledge, but lack of adequate or predicable copyright enforcement in developing countries can prevent the evolution of their own local creative industries, said several representatives from such industries yesterday.
Study Touts Economic Benefits Of Biodiversity 20/10/2010 by Intellectual Property Watch Leave a Comment A study showing the economic benefits of biodiversity and the costs of its destruction was released today at the UN Convention on Biological Diversity conference in Nagoya, Japan.
Medicines Patent Pool Seeks Business Director 19/10/2010 by Intellectual Property Watch Leave a Comment The Medicines Patent Pool, recently established with the support of drug-purchasing mechanism UNITAID, is searching for a new business director to manage relationships with current and potential new licensors and licensees of medicine-related patents. The business development director will help the Medicines Patent Pool general counsel in negotiating licensing arrangements, and is also responsible for […]
WHO Moves IP, Innovation Out Of Director General’s Office 19/10/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment The World Health Organization has moved responsibility for intellectual property and innovation issues out of the direct control of the WHO director general and into the company of information, evidence and research, according to sources.